Literature DB >> 20681988

Expression and secretion of interleukin-1β, tumour necrosis factor-α and interleukin-10 by hypoxia- and serum-deprivation-stimulated mesenchymal stem cells.

Zongwei Li1, Hua Wei, Linzi Deng, Xiangfeng Cong, Xi Chen.   

Abstract

To understand the potential paracrine roles of interleukin-1β (IL-1β), tumour necrosis factor-α (TNF-α) and interleukin-10 (IL-10), the expression and secretion of these factors by rat bone marrow-derived mesenchymal cells stimulated by hypoxia (4% oxygen) and serum deprivation (hypoxia/SD) were investigated. We found that hypoxia/SD induced nuclear factor kappa Bp65-dependent IL-1β and TNF-α transcription. Furthermore, hypoxia/SD stimulated the translation of pro-IL-1β and its processing to mature IL-1β, although the translation of TNF-α was unchanged. Unexpectedly, the release of IL-1β and TNF-α from hypoxia/SD-stimulated mesenchymal cells was undetectable unless ATP or lipopolysaccharide was present. This result suggests that IL-1β and TNF-α are not responsible for the paracrine effects of mesenchymal cells under ischaemic conditions. We also found that hypoxia/SD induced the transcription and secretion of IL-10, which were significantly enhanced by lipopolysaccharide and the proteasomal inhibitor MG132. Moreover, both the conditioned medium from hypoxia/SD-stimulated mesenchymal cells (MSC-CM) and IL-10 efficiently inhibited cardiac fibroblast proliferation and collagen expression in vitro, suggesting that mesenchymal cell-secreted IL-10 prevents cardiac fibrosis in a paracrine manner under ischaemic conditions. Taken together, these findings may improve understanding of the cellular and molecular basis of the anti-inflammatory and paracrine effects of mesenchymal cells.
© 2010 The Authors Journal compilation © 2010 FEBS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20681988     DOI: 10.1111/j.1742-4658.2010.07770.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  12 in total

1.  MicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation treatment through inhibitor of growth family, member 5.

Authors:  Jue Wang; Weicong Huang; Yihe Wu; Jianfeng Hou; Yu Nie; Haiyong Gu; Jun Li; Shengshou Hu; Hao Zhang
Journal:  Stem Cells Dev       Date:  2012-04-20       Impact factor: 3.272

2.  Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.

Authors:  Kapka Miteva; Sophie Van Linthout; Kathleen Pappritz; Irene Müller; Frank Spillmann; Marion Haag; Harald Stachelscheid; Jochen Ringe; Michael Sittinger; Carsten Tschöpe
Journal:  Stem Cells Transl Med       Date:  2016-07-26       Impact factor: 6.940

3.  Therapeutic assessment of mesenchymal stem cells delivered within a PEGylated fibrin gel following an ischemic injury.

Authors:  Laura M Ricles; Pei-Ling Hsieh; Nicholas Dana; Viktoriya Rybalko; Chelsea Kraynak; Roger P Farrar; Laura J Suggs
Journal:  Biomaterials       Date:  2016-06-07       Impact factor: 12.479

4.  In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion.

Authors:  Qiang Shi; Xiaoyan Liu; Yuanyuan Bai; Chuanjue Cui; Jun Li; Yishi Li; Shengshou Hu; Yingjie Wei
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

Review 5.  Coupling Osteogenesis and Vasculogenesis in Engineered Orthopedic Tissues.

Authors:  Nicholas G Schott; Nicole E Friend; Jan P Stegemann
Journal:  Tissue Eng Part B Rev       Date:  2020-09-25       Impact factor: 7.376

6.  Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Umbilical Cord Blood.

Authors:  E V Sotnezova; E R Andreeva; A I Grigoriev; L B Buravkova
Journal:  Acta Naturae       Date:  2016 Jul-Sep       Impact factor: 1.845

7.  Diabetes Stimulates Osteoclastogenesis by Acidosis-Induced Activation of Transient Receptor Potential Cation Channels.

Authors:  Carlotta Reni; Giuseppe Mangialardi; Marco Meloni; Paolo Madeddu
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

Review 8.  Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.

Authors:  Robert G Gourdie; Stefanie Dimmeler; Peter Kohl
Journal:  Nat Rev Drug Discov       Date:  2016-06-24       Impact factor: 84.694

Review 9.  Strategies to improve the immunosuppressive properties of human mesenchymal stem cells.

Authors:  Myoung Woo Lee; Somi Ryu; Dae Seong Kim; Ki Woong Sung; Hong Hoe Koo; Keon Hee Yoo
Journal:  Stem Cell Res Ther       Date:  2015-10-07       Impact factor: 6.832

10.  Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential.

Authors:  Xuejun Sun; Bo Fang; Xi Zhao; Guangwei Zhang; Hong Ma
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.